In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion, and public health priorities in his first ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...

If he is confirmed as Health and Human Services secretary, Robert F. Kennedy Jr. would take over a sprawling bureaucracy with ...

Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate ...